Lot of 2 mg warfarin tablets recalled

Candace Stuart | | Cardiovascular Business | Heart Rhythm

A lot of warfarin 2 mg tablets is under recall for being oversized.

Zydus Pharmaceuticals USA reported that it received one product complaint of four oversized tablets. Ingesting oversized tablets could increase the risk of bleeding, which in a critical organ such as the central nervous system could be fatal. The risk increases with frequency of overdosing.

Zydus had no reports of adverse events.

The affected lot is Lot MM5767 with an expiration date June 2014. The product identifier is NDC 6838205310. It was distributed nationwide in the U.S. between November to December 2012.

Warfarin is prescribed to reduce the risk of stroke in patients with atrial fibrillation. It also is indicated as a prophylaxis and treatment of venous thrombosis and pulmonary embolism and as a prophylaxis and treatment of thromboembolic complications associated with cardiac valve replacement.

Patients with 2 mg tablets from the affected lot should discontinue use, and tablets should be quarantined and returned. Zydus said it is working with customers to arrange for returns.

Candace Stuart, Contributor

Related Content

Eko Health’s AI platform for digital stethoscopes granted new CPT code
Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system
Boston Scientific agrees to acquire AFib ablation company
Heart Rhythm Society launches new group focused on EP advocacy

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup